Comparison of FDG and FLT PET/CT Imaging Based on Human Non-Small Cell Lung Carcinoma Tumor Size in a Small Animal Model

Research Article

Austin J Radiol. 2016; 3(4): 1058.

Comparison of FDG and FLT PET/CT Imaging Based on Human Non-Small Cell Lung Carcinoma Tumor Size in a Small Animal Model

Choi EK¹#, Jung HY²#, Yoo IR¹*, Chung YA¹, Park SI¹ and Maeng LS²

¹Department of radiology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

²Institute of Catholic Integrative Medicine (ICIM), Incheon St. Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea

*Corresponding author: Yoo IR, Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, South Korea #Choi EK and Jung HY contributed equally to this work.

Received: August 26, 2016; Accepted: October 06, 2016; Published: October 12, 2016

Abstract

Our goal was to investigate FDG and FLT uptake based on tumor size and the correlation with Ki-67 staining in an Non-Small Cell Lung Carcinoma (NSCLC) xenograft model. A549 human NSCLC cells were subcutaneously implanted into the flanks of nine nude rats. Standardized Uptake Value (SUV) parameters were obtained from FDG and FLT PET/CT images, including SUVmax, SUVmean, tumor to Non-Tumor Ratio (TNR), and Coefficient Of Variation (COV). SUVmax was higher in FDG PET than in FLT PET imaging (P=0.039). Significant correlations of tumor size with SUVmax, TNR, and COV were observed in FDG imaging (r=0.852, P=0.004; r=0.676, P=0.046; r=0.817, P=0.007), but no such correlations were found in FLT imaging (r=0.195, P=0.615; r=0.419, P=0.261; r=0.117, P=0.764). There were significant correlations of the Ki-67 index with SUVmax, TNR, and COV in FLT imaging (r=0.866, P=0.003; r=0.745, P=0.021; r=0.721, P=0.029), but no such correlations in FDG imaging (r=0.478, P=0.193; r=0.478, P=0.193; r=0.617, P=0.077). Our data demonstrated that FDG uptake was better visualized in the tumor and correlated significantly better with tumor size compared with FLT in an NSCLC xenograft model. The tumor heterogeneity on FDG PET correlated well with tumor size, while no correlation was found for FLT.

Keywords: 18F-FDG; 18F-fluorothymidine; PET; Lung neoplasms

Introduction

Biological markers of tumor growth and proliferation have emerged as important prognostic factors in patients with Non-Small Cell Lung Carcinoma (NSCLC) [1]. The molecular characteristics obtained from measurement of tumor growth and proliferation related to DNA synthesis can be important factors for making treatment plan decisions and selecting optimized anticancer therapy at initial diagnosis. In addition, imaging plays a role in risk stratification and prognosis prediction. Many previous studies have established predictive tools for evaluating the biologic processes affecting tumor growth and aggressiveness [2,3].

Functional imaging techniques such as Positron Emission Tomography (PET) can be useful to obtain information on the biological features of the tumor such as biomarkers of metabolism, proliferation, and hypoxia [4-6]. Fluorodeoxyglucose (FDG) is a widely used radiopharmaceutical that allows assessment of tumor cellular glucose utilization, and the use of FDG PET for the detection, staging, therapeutic response evaluation, and prognosis prediction for NSCLC has been expanding [7-9]. However, FDG is selectively taken up by both tumor cells and inflammatory cells, which results in falsepositive findings. To overcome this flaw, several PET tracers targeting proliferation and hypoxia of the tumor cell have been developed. In addition, new PET tracers for fatty acid, choline metabolism, amino acid transport, and protein synthesis have been introduced, although they are not yet widely available.

Attempts to assess the cellular proliferative activity have been made with several DNA precursors that are involved in the DNA replication phase [10,11]. Of the agents that target DNA synthesis, F-18 Fluorothymidine (FLT) has been widely exploited in clinical oncology because of its favorable metabolic rate, optimal half-life, and commercial availability [12,13]. Compared with FDG, FLT shows higher discrimination between tumor and inflammatory cells and has fewer false-positive findings [14,15]. However, several studies have shown that the uptake of FLT is not clearly visualized and shows low sensitivity in NSCLC [16]. FLT uptake may vary based on Ki-67 expression, which binds to nuclear antigens expressed by cells in the G1, G2, M, and S proliferative phases [17]. Furthermore, whether the amount of FLT uptake depends on tumor size remains unclear, while studies have shown that the degree of FDG uptake correlates directly with tumor size [5]. This uncertainty may be due in part to tumor heterogeneity caused by differences in the tumor microenvironment and differences in proliferation, hypoxia, and necrosis [18,19]. To our knowledge, few studies have directly compared FDG and FLT imaging techniques with regard to tumor size. To understand the relationship between FDG and FLT uptake and tumor size, the correlation between FDG and FLT uptake by tumor size was evaluated in an NSCLC xenograft model. Therefore, the aim of our study was to compare FDG and FLT uptake according to tumor size and demonstrate the correlation with the proliferative activity in an NSCLC xenograft model.

Materials and Methods

Tumor cell culture

Human NSCLC A549 cells were obtained from American Type Culture Collection (Manassas, VA, USA, http://www.atcc.org) and maintained in Dulbecco’s modified Eagle’s medium (DMEM; Hyclone, Logan, UT, USA) including 10% heat-inactivated fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin. The cells were incubated at 37°C in a humidified atmosphere containing 5% CO2.

Animal models

The experimental protocol was approved by the Institutional Animal Care and Use Committee of Catholic University Medical School, and all experiments were performed in accordance with our institutional guidelines. Six-week-old male athymic Crl: NIHFoxn1rnu rats (Charles River) were housed in an optimal temperature-, humidity-, and light-controlled environment. Food and water were freely available. For the tumor xenograft model, the rats were anesthetized with 5% isoflurane in 70% nitrous oxide and 30% oxygen using an induction chamber and maintained by a mixture of 2% isoflurane under temperature-controlled conditions (37°C ± 0.1°C). After receiving anesthesia, a single dose of 1 × 107 A549 tumor cells in 200 μl of DMEM was injected subcutaneously into the flank of the rats. After tumor implantation, the tumor diameter was measured daily with calipers to monitor growth. When the nodular lesion on the tumor implant site grew to >5 mm in gross diameter, it was selected for the PET/CT experiment. PET/CT imaging was performed on a different date for each rat to assess metabolic activity according to the tumor size.

PET using F-18 FDG and F-18 FLT

After the rats were anesthetized with intraperitoneal injection of ketamine (80 mg/kg) and xylazine (10 mg/kg), about 37 MBq (0.5 ml) of the radiotracer (either FDG or FLT) was injected intravenously via a lateral tail vein. After allowing the radiotracer to distribute for 1 h, the rats were anesthetized for the PET/CT scan. PET/CT images were acquired for 20 min over a single 16.4-cm bed position while keeping the animal warm with a heating pad (Biograph mCT; Siemens Medical Systems). All rats fasted for at least 6 h prior to FDG PET/ CT scanning, but had access to water at all times. Each rat underwent both FDG and FLT PET/CT scans on two different days (1–2 days apart).

Histological examination

Nine rats were killed and the tumors removed for histological examination within 24 h after the last PET/CT scan. The tumor was completely excised and separated from the adjacent muscle and skin. The tumors were fixed in 10% formalin for 24 h before embedding in paraffin. The blocks were cut into 5-μm sections and stained with hematoxylin and Eosin (H&E). To perform immunohistochemistry, the sections were dewaxed in Histoclear (Sigma, St. Louis, MO, USA) and rehydrated through a graded alcohol series. After antigen retrieval (Abcam, Cambridge, MA, USA), immunohistochemistry was performed in accordance with the manufacturer’s protocols using the EnVision + Dual System-HRP (Dako, Glostrup, Denmark). Briefly, the sections were blocked with endogenous enzyme. The sections were incubated with the rabbit polyclonal antibody to Ki-67 (Abcam). Immunoreactivity was visualized with 3.3’-diaminobenzine, and the sections were counterstained with hematoxylin. All microscopy images were acquired using a slide scanner (3DHISTECH Ltd., Budapest, Hungary) and a microscope equipped with a spot digital camera (Nikon, Tokyo, Japan). The optical density of Ki-67-positive cells in the tumor area was determined using the MetaMorph imaging program (Molecular Device Inc., Downingtown, PA, USA). To exclude necrotic areas, corresponding sections stained with H&E were examined. The lesion with the highest density of Ki-67 was selected, and the total tumor cells and Ki-67-positive cells were counted. The Ki67 index was calculated by the fraction of Ki-67-positive samples in at least 500 tumor cells.

Data analysis

All PET/CT images were transferred to a workstation with a fusion software system (Mirada Medical, Oxford, UK) that provided multiplanar reformatted images and displayed PET images after attenuation correction, CT images, and PET/CT fusion images. The volume of interest of the tumor was delineated manually in the tumor on the basis of CT images, and the long diameter (cm) and volume (cm3) of the tumor were measured. On PET images, the highest intensity of FDG and FLT uptake within the tumor volume of interest was quantified by calculating the maximum standardized uptake value (SUVmax) and the mean standardized uptake value (SUVmean). The Tumor to Non-Tumor Ratio (TNR) was calculated with background activity of normal lung tissue using the following formula:

TNR = SUVmax of the tumor / SUVmean of the normal lung

Tumor heterogeneity was estimated using the Coefficient Of Variation (COV), defined as the standard deviation divided by the SUVmean in the delineated tumor.

Statistical analyses were performed using the Statistical Package for Social Sciences (SPSS) software (version 13.0). Pearson coefficients were used to compare SUV parameters (SUVmax, TNR, and COV) for FDG and FLT with tumor size and the amount of Ki- 67 staining. Student’s t test was used for parametric data to compare SUV parameters between FDG and FLT. Values are presented as the mean value ± standard deviation. A P value of <0.05 was considered statistically significant.

Results

Comparison of cellular uptake of radiotracer between FDG and FLT uptake

In total, nine tumor lesions were identified in the rats, and the average tumor size measured on CT images of PET/CT was 1.86 ± 1.32 cm. FDG uptake was clearly visualized with variable intensity in all tumors, while FLT uptake was not obvious in five tumors. FDG PET showed focal uptake in discrete regions of the tumor volume, more so than seen in the corresponding FLT PET images (Figure 1). SUVmax in FDG PET was higher than that obtained for FLT PET (1.94 ± 1.13 vs 1.00 ± 0.37, P = 0.039). There was no significant difference in TNR or COV between FDG PET/CT and FLT PET/CT. There were no significant correlations of SUVmax, TNR, or COV between FDG PET and FLT PET. The mean values of SUVmax, TNR, and COV are shown in Table 1.